FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225540723> ?p ?o ?g. }

• W4225540723 endingPage "1245" @default.
• W4225540723 startingPage "1236" @default.
• W4225540723 abstract "Abstract Identification of ovarian cancer patient subpopulations with increased sensitivity to targeted therapies could offer significant clinical benefit. We report that 22% of the high-grade ovarian cancer tumors at diagnosis express CIP2A oncoprotein at low levels. Furthermore, regardless of their significantly lower likelihood of disease relapse after standard chemotherapy, a portion of relapsed tumors retain their CIP2A-deficient phenotype. Through a screen for therapeutics that would preferentially kill CIP2A-deficient ovarian cancer cells, we identified reactive oxygen species inducer APR-246, tested previously in ovarian cancer clinical trials. Consistent with CIP2A-deficient ovarian cancer subtype in humans, CIP2A is dispensable for development of MISIIR-Tag–driven mouse ovarian cancer tumors. Nevertheless, CIP2A-null ovarian cancer tumor cells from MISIIR-Tag mice displayed APR-246 hypersensitivity both in vitro and in vivo. Mechanistically, the lack of CIP2A expression hypersensitizes the ovarian cancer cells to APR-246 by inhibition of NF-κB activity. Accordingly, combination of APR-246 and NF-κB inhibitor compounds strongly synergized in killing of CIP2A-positive ovarian cancer cells. Collectively, the results warrant consideration of clinical testing of APR-246 for CIP2A-deficient ovarian cancer tumor subtype patients. Results also reveal CIP2A as a candidate APR-246 combination therapy target for ovarian cancer." @default.
• W4225540723 created "2022-05-05" @default.
• W4225540723 creator A5004114938 @default.
• W4225540723 creator A5008528112 @default.
• W4225540723 creator A5010863055 @default.
• W4225540723 creator A5022556102 @default.
• W4225540723 creator A5029864070 @default.
• W4225540723 creator A5030148031 @default.
• W4225540723 creator A5040691385 @default.
• W4225540723 creator A5043341222 @default.
• W4225540723 creator A5045989882 @default.
• W4225540723 creator A5049950699 @default.
• W4225540723 creator A5055369999 @default.
• W4225540723 creator A5063778910 @default.
• W4225540723 creator A5068244748 @default.
• W4225540723 creator A5075171256 @default.
• W4225540723 creator A5082122641 @default.
• W4225540723 creator A5091434519 @default.
• W4225540723 date "2022-04-01" @default.
• W4225540723 modified "2023-10-14" @default.
• W4225540723 title "Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype" @default.
• W4225540723 cites W1523852619 @default.
• W4225540723 cites W1682873785 @default.
• W4225540723 cites W1978782811 @default.
• W4225540723 cites W1979520552 @default.
• W4225540723 cites W2006422601 @default.
• W4225540723 cites W2023303889 @default.
• W4225540723 cites W2046057377 @default.
• W4225540723 cites W2058933349 @default.
• W4225540723 cites W2068551536 @default.
• W4225540723 cites W2073664416 @default.
• W4225540723 cites W2077276508 @default.
• W4225540723 cites W2083459920 @default.
• W4225540723 cites W2093226733 @default.
• W4225540723 cites W2099186537 @default.
• W4225540723 cites W2123749436 @default.
• W4225540723 cites W2137956841 @default.
• W4225540723 cites W2162268427 @default.
• W4225540723 cites W2290932118 @default.
• W4225540723 cites W2355389606 @default.
• W4225540723 cites W2587854885 @default.
• W4225540723 cites W2756233751 @default.
• W4225540723 cites W2762077288 @default.
• W4225540723 cites W2763322182 @default.
• W4225540723 cites W2776139938 @default.
• W4225540723 cites W2793353239 @default.
• W4225540723 cites W2884137656 @default.
• W4225540723 cites W2898899650 @default.
• W4225540723 cites W2899159263 @default.
• W4225540723 cites W2922111584 @default.
• W4225540723 cites W2979766702 @default.
• W4225540723 cites W2991491391 @default.
• W4225540723 cites W3008581670 @default.
• W4225540723 cites W3109819734 @default.
• W4225540723 cites W3110888894 @default.
• W4225540723 cites W3131928636 @default.
• W4225540723 cites W3140922284 @default.
• W4225540723 cites W3169418599 @default.
• W4225540723 doi "https://doi.org/10.1158/1535-7163.mct-21-0622" @default.
• W4225540723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35364610" @default.
• W4225540723 hasPublicationYear "2022" @default.
• W4225540723 type Work @default.
• W4225540723 citedByCount "2" @default.
• W4225540723 countsByYear W42255407232023 @default.
• W4225540723 crossrefType "journal-article" @default.
• W4225540723 hasAuthorship W4225540723A5004114938 @default.
• W4225540723 hasAuthorship W4225540723A5008528112 @default.
• W4225540723 hasAuthorship W4225540723A5010863055 @default.
• W4225540723 hasAuthorship W4225540723A5022556102 @default.
• W4225540723 hasAuthorship W4225540723A5029864070 @default.
• W4225540723 hasAuthorship W4225540723A5030148031 @default.
• W4225540723 hasAuthorship W4225540723A5040691385 @default.
• W4225540723 hasAuthorship W4225540723A5043341222 @default.
• W4225540723 hasAuthorship W4225540723A5045989882 @default.
• W4225540723 hasAuthorship W4225540723A5049950699 @default.
• W4225540723 hasAuthorship W4225540723A5055369999 @default.
• W4225540723 hasAuthorship W4225540723A5063778910 @default.
• W4225540723 hasAuthorship W4225540723A5068244748 @default.
• W4225540723 hasAuthorship W4225540723A5075171256 @default.
• W4225540723 hasAuthorship W4225540723A5082122641 @default.
• W4225540723 hasAuthorship W4225540723A5091434519 @default.
• W4225540723 hasBestOaLocation W42255407232 @default.
• W4225540723 hasConcept C121608353 @default.
• W4225540723 hasConcept C126322002 @default.
• W4225540723 hasConcept C143998085 @default.
• W4225540723 hasConcept C150903083 @default.
• W4225540723 hasConcept C203014093 @default.
• W4225540723 hasConcept C207001950 @default.
• W4225540723 hasConcept C2780427987 @default.
• W4225540723 hasConcept C502942594 @default.
• W4225540723 hasConcept C71924100 @default.
• W4225540723 hasConcept C86803240 @default.
• W4225540723 hasConceptScore W4225540723C121608353 @default.
• W4225540723 hasConceptScore W4225540723C126322002 @default.
• W4225540723 hasConceptScore W4225540723C143998085 @default.
• W4225540723 hasConceptScore W4225540723C150903083 @default.
• W4225540723 hasConceptScore W4225540723C203014093 @default.
• W4225540723 hasConceptScore W4225540723C207001950 @default.

• next